Home > Insider Trading > Filing (0001765581-22-000057)

Filing Details

Accession Number:: 0001765581-22-000057
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-06-08 16:56:42
Reporting Period:: 2022-06-06

Accepted Time:: 2022-06-08 16:56:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1232524	Jazz Pharmaceuticals Plc	JAZZ	Pharmaceutical Preparations (2834)	981032470

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1758790	Kim Sablich	5Th Fl, Waterloo Exchange Waterloo Rd Dublin 4 L2	Evp & Gm, North America	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Disposition	2022-06-06	1,759	$149.25	28,583	No	4	F	Direct
Ordinary Shares	Disposition	2022-06-06	1,388	$152.15	27,195	No	4	S	Direct
Ordinary Shares	Disposition	2022-06-07	200	$148.21	26,995	No	4	S	Direct
Ordinary Shares	Disposition	2022-06-07	250	$149.22	26,745	No	4	S	Direct
Ordinary Shares	Disposition	2022-06-07	573	$150.68	26,172	No	4	S	Direct
Ordinary Shares	Disposition	2022-06-07	1,317	$151.87	24,855	No	4	S	Direct
Ordinary Shares	Disposition	2022-06-07	101	$152.60	24,754	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $148.05 to $148.36. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $149.12 to $149.70. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $150.32 to $151.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $151.35 to $152.21. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.595 to $152.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.